Navigation Links
Promising Results in Treating Facial Bruising From Injectables
Date:9/26/2007

Top physician leading clinical trials

FREEPORT, N.Y., Sept. 26 /PRNewswire/ -- Physicians nationwide report promising results in treating facial bruising from injectable cosmetic treatments by using Pinoxide(TM), an active ingredient best known for treating under-eye circles.

Pinoxide is a proprietary blend of bicyclic monoterpene dials (BMTd) created by AGI Dermatics and formulated in the company's Remergent Microcirculation Therapy product. Pinoxide has been clinically proven to speed blood flow, warm the skin, increase resistance to cold, and reduce dark under- eye symptoms. Additional research suggests Pinoxide may also contribute to promoting firmness and resiliency in the skin. Now, physicians are studying the ingredient's ability to heal bruising.

Dr. Mark G. Rubin, a board-certified dermatologist currently practicing at the Lasky Clinic in Beverly Hills, is conducting the clinical trials on Pinoxide, applying the Microcirculation Therapy formula to the injection site immediately after use of skin fillers such as collagen, Restylane and Juvederm, or Botox.

"Anatomically speaking, dark circles are like bruises - so the science behind using Pinoxide for bruising makes total sense," said Dr. Rubin. "The skin discoloration during bruising is the result of blood leaking from damaged blood vessels and surfacing to the skin. Similarly, blood vessels under the eyes can burst, leading to the appearance of unattractive dark circles."

Leading dermatologists share Dr. Rubin's opinion. Dr. Thomas Francel, a board certified plastic surgeon, has found that application of MicroCirculation Therapy on his patients reduces the appearance of skin bruising, and decreases the amount of healing time for the bruise. Dr. Francel is the Chief of Plastic Surgery at St. John's Mercy Medical Center and an Associate Professor of Surgery at St. Louis University.

Injectable cosmetic treatments are among the five top most requested a
'/>"/>

SOURCE AGI Dermatics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
5. Antisense Pharma: Promising Phase IIb Results of Targeted Therapy with AP 12009 in Recurrent Anaplastic Astrocytoma
6. Promising Data on Cognitive Effects of Safinamide in Early Parkinsons Disease
7. Promising Results with Epratuzumab and Chemotherapy in Children with Acute Lymphoblastic Leukemia
8. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
9. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
10. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
11. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)..., , THOUSAND OAKS, Calif., Dec. 3 /PRNews...duate students from across the United States (U.S....gram to gain hands-on laboratory experience under ...iversities. Now, the Amgen Scholars - past, prese...online Amgen Scholars Community at www.amgenschol...
(Date:12/3/2009)..., , MOUNTAIN VIEW, Calif., Dec. 3 /PRN...OMCL ) a leading provider of medication system sol...nced that Carolinas HealthCare System (CHS), the...ird largest non-profit public system in the nation...ation dispensing cabinets (ADCs) to streamline man...
(Date:12/3/2009)..., , PISCATAWAY, N.J., Dec. 3 /PRNewswir...letin Board: MLSS), the recognized leader in advan...t had entered into a joint venture with China Nati...) and Yichang Humanwell Pharmaceutical Co. Ltd., b... (the "PRC"), to develop orthopedic and epidural d...
Breaking Medicine Technology:New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists 2New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists 3Omnicell Selected by Nation's Third Largest Public Healthcare System for Medication Management Systems 2Omnicell Selected by Nation's Third Largest Public Healthcare System for Medication Management Systems 3Omnicell Selected by Nation's Third Largest Public Healthcare System for Medication Management Systems 4Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments 2Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments 3Boston Scientific to Participate in Thomas Weisel Partners Health Care Conference 56269 1Boston Scientific to Participate in Thomas Weisel Partners Health Care Conference 56269 2Green Bridge Industries Inc to Exhibit ZAP 28TM 29 Stain Remover Pen at the L A County Fair 56267 1Green Bridge Industries Inc to Exhibit ZAP 28TM 29 Stain Remover Pen at the L A County Fair 56267 2Partnership for Prescription Assistance Prepared to Help Kentucky Workers Hurt by Recession 56266 1Partnership for Prescription Assistance Prepared to Help Kentucky Workers Hurt by Recession 56266 2Partnership for Prescription Assistance Prepared to Help Kentucky Workers Hurt by Recession 56266 3
...YORK, March 27 Keryx Biopharmaceuticals,Inc. (Nas... Safety and,Monitoring Committee (DSMC) review of ...xide oral gelcap), the Company has decided to term...ulonex., The Company previously announced via con... suspended pending an interim analysis, following ...
...Approves Label Revisions Recommending New Weight-B...Schering-Plough Corporation,(NYSE: SGP ) today re...(FDA),has approved label revisions for PEGINTRON(T...in, USP) combination therapy for chronic hepatitis...0-1400 mg daily) based on,patient body weight. The...
Other Medicine Technology:Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial 2Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial 3Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C 2Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C 3Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C 4Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C 5Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C 6Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C 7Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C 8
(Date:12/3/2009)...c. 3 The day has come. Eight month...t prominent direct-care RN organizations will gath...convention of the new 150,000-member National Nurs...ssociation in U.S. history. ,, AFL-CIO Presiden... the convention which will chart a course for the ...
(Date:12/3/2009)...A, Fla., Dec. 3 If you have seen "...dy for a stunning look at the other side of the di...ll screen her feature documentary, "Supercharge Me...ecember 8th, 5 p.m. at Sever Hall, Harvard Yard. T..." College Tour. The film will be followed by a lec...
(Date:12/3/2009)...l Institute (HHMI) researchers have identified a n... many forms of medulloblastoma, the most common ty...vestigator Huda Y. Zoghbi and colleagues at Baylor...m developing in mice by shutting down production o...e team,s findings, reported in the December 4, 200...
(Date:12/3/2009)...rom replicating in the livers of primates , , ...w drug to treat hepatitis C has shown promise in a...s a new strategy to prevent the hepatitis C virus ...get the virus itself, the new DNA-based drug targe...s C needs to replicate, the researchers explained....
(Date:12/3/2009)...Germany, PARSIPPANY, N.J. and ANDOVER, Mass., Dec....prise Image Intelligence® company, and Visage...Pro Medicus Ltd. (ASX: PME) announced today that t...elop and market advanced oncology solutions for th...he partnership enables Definiens to utilize the Vi...
Breaking Medicine News(10 mins):Health News:RN SuperUnion Founding Convention Opens Monday 2Health News:Jenna Norwood to Present Award-Winning Documentary & Lecture at Harvard University 2Health News:Researchers identify gene that spurs deadly brain cancer 2Health News:Researchers identify gene that spurs deadly brain cancer 3Health News:New Hepatitis C Treatment Shows Promise 2Health News:New Hepatitis C Treatment Shows Promise 3Health News:Visage Imaging and Definiens Announce Partnership 2Health News:Visage Imaging and Definiens Announce Partnership 3
...ies Significant Added Benefits Over ...GTON, Nov. 6 Patients with ischemia, or clogged,a...oronary intervention,(PCI) when compared with opti...is sub-study is especially significant given that ...
...ischarge rates in Cypress Creek and ...s, Nov. 6 Texas,s Cypress Creek EMS,has participa... techniques,the results of which support the wides...ns on November 4 in Orlando.,Lead author, Tom P. A...
...of patient safety findings, group says , TUESDAY, ...be used as hospital safety rating tools have been ...aid the guidelines could help do away with mislead... long overdue, the data is only helpful if it,s ac...
...essure are driving the trend, study says , ... of Americans with chronic kidney disease is on th...d to obesity appear to account for most of the inc...ead researcher Dr. Josef Coresh, a professor of ep...
... Infectious Diseases (NIAID), part of the National... to strengthen and expand its nationwide group of ...ng candidate vaccines and therapies for infectious...y out more clinical trials in larger populations a...
... 6 ,Boston Scientific Corporation (NYSE: BSX ) an...ndustry,s first patient data integration between a...m and a physician,s,electronic medical record, cur...ement,system to allow clinicians to access informa...
Other Medicine News:Health News:COURAGE Sub-study: PCI Outperforms Drugs-Only 2Health News:COURAGE Sub-study: PCI Outperforms Drugs-Only 3Health News:COURAGE Sub-study: PCI Outperforms Drugs-Only 4Health News:Cypress Creek in National Study, Shows Survival To Hospital Discharge After Cardiac Arrest Doubles with Improved CPR and Impedance Threshold Device 2Health News:Cypress Creek in National Study, Shows Survival To Hospital Discharge After Cardiac Arrest Doubles with Improved CPR and Impedance Threshold Device 3Health News:Kidney Disease Increasing in U.S. 2Health News:Kidney Disease Increasing in U.S. 3Health News:NIAID strengthens and expands Vaccine and Treatment Evaluation Units 2Health News:NIAID strengthens and expands Vaccine and Treatment Evaluation Units 3Health News:Boston Scientific and GE Healthcare Announce their First Patient Data Link to Electronic Medical Record 2Health News:Boston Scientific and GE Healthcare Announce their First Patient Data Link to Electronic Medical Record 3Health News:Boston Scientific and GE Healthcare Announce their First Patient Data Link to Electronic Medical Record 4Health News:Boston Scientific and GE Healthcare Announce their First Patient Data Link to Electronic Medical Record 5
HemoPoint H2 Hemoglobin Measurement System
Chemstrip Micral
...unoassay for urinary albumin that allows for early...c, CLIA Waived test has a sensitivity of 18 mg/L a...in only 3 minutes with stable viewing results up t...venting kidney disease, the ICON®microALB allo...
...ilable in 14 configurations including the newest a...s Antibody Technology, the SureStep MDMA (Ecstasy)...ed to detect MDMA that has an affinity for both MD...f methamphetamine or amphetamine. The SureStep Dru...
Medicine Products: